Ardelyx Inc Drug Patent Portfolio

Ardelyx Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ardelyx Inc News

Ardelyx Patent Prolongs Tenapanor Brand's Strategic Outlook Until 2042

07 Feb, 2026

See More